Filter
Sort
Issue 4
Issue 4

People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce t...

Expired: 03.09.2022
Issue 3
Issue 3

People who inject drugs (PWID) account for nearly 10% of new HIV infections. With the rate of injection drug use continuing to rise, the need for effe...

Expired: 03.01.2022
Issue 2
Issue 2

The extrahepatic manifestations of chronic HCV can affect many different organ systems. In this eViralHepatitis Review podcast, Dr. Rajender Reddy fro...

Expired: 02.27.2022
Issue 1
Issue 1

While the hepatic manifestations of hepatitis C infection (HCV) (eg, cirrhosis and liver cancer) are well known, the extrahepatic manifestations are a...

Expired: 02.13.2022
Issue 2
Issue 2

In her recent newsletter issue (eHIV Review V5 #1), Dr. Ethel Weld, Assistant Professor of Medicine, Pharmacology and Molecular Sciences at the Johns...

Expired: 12.22.2021
Issue 1
Issue 1

The current gold standard for HIV treatment — triple drug therapy — is evolving. Dual drug regimens — two drugs from two separate cl...

Expired: 12.15.2021
Issue 12
Issue 12

“U=U” — an Undetectable HIV viral load means Untransmittable HIV virus. In her recent eHIV Newsletter Issue (Vol. 4; No. 11), Dr. Ji...

Expired: 07.24.2021
Issue 11
Issue 11

U=U: Undetectable = Untransmittable. People with HIV viral loads so low as to be undetectable — are they really no longer able to transmit the v...

Expired: 07.01.2021
Issue 2
Issue 2

PrEP — pre-exposure prophylaxis to prevent HIV transmission — is safe, it’s effective, and it’s significantly underused in the...

Expired: 06.14.2021
Issue 1
Issue 1

Randomized trials have demonstrated that HIV pre-exposure prophylaxis (PrEP) is highly efficacious at preventing HIV acquisition. To date, however, up...

Expired: 06.14.2021
Issue 10
Issue 10

Evidence-based plans to improve adherence — how do they work in practice? How can they most effectively be tailored to each patient’s need...

Expired: 05.30.2021
Issue 8
Issue 8

Should all patients with cirrhosis be treated immediately for hepatitis C infection? What are the circumstances when it’s better for patients to...

Expired: 04.25.2021
Issue 9
Issue 9

Many people living with HIV/AIDS (PLWHA) can achieve near-normal life expectancy, suppressed viral load, and lower risk of HIV-related illnesses and c...

Expired: 04.24.2021
Issue 7
Issue 7

Well-tolerated direct-acting antiviral medications (DAAs) can achieve sustained virological response (SVR) in at least 95% of all patient populations...

Expired: 04.18.2021
Issue 6
Issue 6

In this podcast follow-up to their recent eViralHepatitis Review newsletter issue (Vol. 6, No. 5), Dr. Mandana Khalili and Dr. Michele Tana from the U...

Expired: 04.07.2021
Issue 8
Issue 8

While newer antiviral agents like darunavir and the integrase strand transfer inhibitor (INSTI) dolutegravir have shown great efficacy, recent postmar...

Expired: 03.27.2021